Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Taiwan
Amivantamab

TFDA 2026

Amivantamab

Rybrevant Solution for Injection 160 mg/mL

注射液劑TaiwanAuthorisedAuthorised 10 Jun 2026

Ask Osler about it

On this page

In other countries
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

RybrevantBrazil · Janssen-Cilag Farmacêutica LtdaSame brand
RybrevantCanada · 350 MG / 7 ML · Solution · Janssen INCSame brand
Rybrevant SCCanada · 1600 MG / 10 ML · Solution · Janssen INCSame brand
Rybrevant SCCanada · 2400 MG / 15 ML · Solution · Janssen INCSame brand
Rybrevant 1600 MG Solucion InyectableSpain · 1600 mg · solución inyectable · Janssen-Cilag International N.VSame brand
Rybrevant 2240 MG Solucion InyectableSpain · 2240 mg · solución inyectable · Janssen-Cilag International N.VSame brand
Rybrevant 2400 MG Solucion InyectableSpain · 2400 mg · solución inyectable · Janssen-Cilag International N.V

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Same brand

🇪🇺RybrevantEuropean Union · Janssen-Cilag International N.V.Same brand

🇭🇷RybrevantCroatiaSame brand

🇮🇹RybrevantItaly · Soluzione iniettabile · Janssen-Cilag International N.V.Same brand

🇳🇱Rybrevant 1600 mg, oplossing voor injectieNetherlands · Oplossing voor injectie · Janssen-Cilag International NVSame brand

🇳🇱Rybrevant 2.400 mg oplossing voor injectieNetherlands · Oplossing voor injectie · Janssen-Cilag International NVSame brand

🇳🇱Rybrevant 2240 mg, oplossing voor injectieNetherlands · Oplossing voor injectie · Janssen-Cilag International NVSame brand

🇷🇸Rybrevant®Serbia · 350mg/7mL · koncentrat za rastvor za infuziju · PredstavniŠTvo Janssen-Cilag KFT BeogradSame brand

🇸🇬Rybrevant Concentrate for Solution for Infusion 350MG/7MLSingapore · 350mg/7ml · infusion, solution concentrate · Johnson & Johnson International (Singapore) Pte LTDSame brand

🇺🇸RybrevantUnited States · 350MG/7ML · injectable · Janssen BiotechSame brand

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Taiwan Food and Drug Administration

TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates

Licence: Taiwan Government Open Data Licence 1.0 · Added 7 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Amivantamab
Dosage form: 注射液劑
Register: Taiwan (TFDA)
Status: Authorised
Authorised: 10 Jun 2026
Registration: 衛部菌疫輸字第001329號
Marketing authorisation holder: 嬌生股份有限公司
Procedure: 菌　疫